Enlisting local media in recruitment for HIV vaccine trials: the Botswana experience
Authors: T.L. Villafana, C. Cunningham, R. Hambira, M. M. Schaan, M. J. Mahkema, M. Mkandla, B. Ratshaa, G. Goodwin, K. Matshediso, P. Thumbi, P. N. Mazonde, I. Thior, M. Essex. Abstract number: ThPeC7429

Behavior:

Can the impact of an HIV vaccine be negated by increases in sexual risk behaviour?
Authors: P.T. Vickerman, A.M. Foss, C.H. Watts, J. Rowley. Abstract number: ThOrC1430

Social impact and harm among injecting drug users (IDUs) in a Phase III HIV vaccine trial in Thailand Authors: P. Pitisuttithum, M. Martin, S. Vanichensi, F. van Griensven, J.W. Tappero, U. Sangkum, E. Vimuthisonthorn, C. Gee, K. Choopanya. Abstract number: C11162

Successfully assessing community sexual behaviors during HIV vaccine cohort development in Kericho, Kenya Authors: R. Kamau, G. Foglia, D. Chuma, J. Ondego, L. Langat, D. Birx, M. Robb. Abstract number: MoPeD3977

Risk factors and incidence of HIV infection among injecting drug users (IDUs) participating in the AIDSVAX B/E HIV vaccine efficacy trial, Bangkok Authors: S. Vanichseni, F. van Griensven, B. Metch, P. Pitisuttithum, M. Martin, D. Kityaporn, J.W. Tappero, A. Luck, K Choopanya. Abstract number: TuPpC2043

HIV incidence among AIDSVAX B/B vaccine trial participants in Montreal, Toronto and Vancouver Authors: T.M. Lampinen, K.J. Chan, K. Logue, J. Vincelette, R.S. Hogg, R.S. Remis, B. Willoughby, K. Linnen, J.L. Roy, N. McLean, V. Popovic. Abstract number: ThOrC1432

­ Circumstances and choice of first and subsequent sexual encounters in potential Phase I HIV vaccine participants in Soweto Authors: K. Mesesan, M. Bogoshi, L.Niccolai, G. Gray, J. McIntyre, E. Vardas. Abstract number: ThPeC7438

HIV vaccine literacy in the developing world: experiences from Kenya Authors: J.O. Ndinya-Achola, A.O. Anzala, D. Mbori-Ngacha, R. Nduati, E.N. Ngugi, W.G. Jaoko, J.J. Bwayo Abstract number: A10060.

The impact of Phase III efficacy trials on community involvement, support, and awareness of HIV vaccine research: a case study of the AIDSVAX trials Author: E.S.L. Lee. Abstract number: ThOrC1429

HIV vaccine acceptability in seronaive patients in a resource limited setting: a pilot study Authors: O.A. Olasode, O.A. Olaogun. Abstract number: ThPeA6978

HIV vaccine acceptability among communities at risk: disparities in perceived barriers and concerns (Project VIBE) Authors: P.A. Newman, W.E. Cunningham, S.J. Lee, E.T. Rudy, R. Seiden, N. Duan. Abstract number: TuPeD5105

Evaluation of SA HIVAC workshop on HIV vaccine development Authors: P.C. Goliath, M. Stuurman, L. Ogle. Abstract number: C12751

Research requirements for community preparedness in testing an HIV vaccine in Africa: A qualitative assessment of stakeholder opinions Authors: D.G. Willms, P.Ritvo, S. Nixon, M. Warren. Abstract number: D12836

Building ownership for HIV vaccines in India Authors: A. Nayyar, S. Menon, M. Chataway, A. Sinha. Abstract number: E11642

Preparing Kenyan communities for HIV/AIDS vaccine trials in Kenya Authors: J.N. Kimani, P. Irungu, A.G. Ragi. Abstract number: ThPeC7455

Re-messaging AIDS awareness campaigns in community engagement for the prime-boost HIV vaccine Phase III trial in Chon Buri and Rayong, Eastern Thailand Authors: N. Thaitawat, D. Buraparat, V. Chaiwong. Abstract number: C12745

Community preparedness and involvement in HIV vaccine trials Authors: P.C. Goliath, M. Stuurman, L. Ogle. Abstract number: C11935

Linking girls' football to HIV vaccine feasibility studies: a participatory peer-education initiative on the Kenya coast Authors: E.M. van der Elst, S. Forde, R. Kombe, A. Khombe, A. Davies, E.J. Sanders, C. S. Molyneux. Abstract number: D12577

Knowledge and willingness to participate in HIV vaccine trials in a young, racially diverse population in Atlanta Authors: F.H. Priddy, A.J. Cheng, L.F. Salazar, P. Frew. Abstract number: ThPeC7431

Developing tools to 'test' understanding in HIV vaccine trials in South Africa Authors: C. Milford, G.C. Lindegger, C. Slack. Abstract number: ThPeC7582

Worth the paper it's written on: Creating a community-oriented AIDS vaccine newsletter that is relevant and useful on four continents Authors: E. Bass, S. Kalibala, M.Warren, A. Menezes, E. Mugisha. Abstract number: ThPeE8132

Involving the community of Lima in HIV vaccine trials Authors: P. Goicochea, C. Bazan, J. Lama, A. LaRosa, C. Sanchez, M. Fernandez-Maldonado, S. Sanchez, R. Galvan, G. Toribio, J.L. Sanchez, J. Sanchez. Abstract number: E11407

Participatory research for HIV vaccine trials: Homeless youths' receptivity and behavioural responses Authors: D. Koniak-Griffin, A. Nyamanthi. Abstract number: ThPeC7428

Collaborating with NGOs and community groups to raise AIDS awareness and to engge the community to participate in the prime-boost HIV vaccine Phase III trial in Chon Buri and Rayong, Eastern Thailand Authors: N. Thaitawat, S. Nacapew, V. Chaiwong, D. Buraparat, B. Donmon, C. Khamboonruang, S. Rerks-Ngarm, N. Thien-Udom. Abstract number: ThPeC7448

HIV vaccine preparedness: Capacity-building needs of community-based AIDS organizations Authors: M.A. LeBlanc, D. Thompson, P. Ritvo. Abstract number: MoPeE4055

Community preparedness towards HIV vaccines, microbicides, and other preventative technologies Authors: F. Yabit, M.A. Torres. Abstract number: TuPeE5526

From theory to practice: expectation vs. success in community engagement in conducting the prime-boost HIV vaccine Phase III trial in Chon Buri province, eastern Thailand Authors: S. Wattana, C. Pobsuk, N. Thamkittikhun, R. Amphaipis, S. Wichianprapai, S. Prodsathapom, S. Jetsukontom, S. Klinhom, S. Siriratanachai. Abstract number: ThPeC7433

From theory to practice: lessons learned in community engagement in conducting the prime-boost HIV vaccine Phase III trial in Rayong province, eastern Thailand Authors: W. Wiriyakijja, K. Palasudhi, C. Tontichaiwanich, B. Theanamnuay, S. Thanomthrup, A. Suwannapitak, S. Phetrasuwan, S. Sukondhagasorn. Abstract number: ThPeC7434

Engaging the communities in Chon Buri and Rayong provinces, eastern Thailand, to participate in the prime-boost HIV vaccine Phase III trial Authors: N. Thaitawat, W. Wiriyakijja, S. Wattana, K. Palasudhi, S. Chunsuttiwat, D. Buraparat, V. Chaiwong, C. Khamboonruang, S. Rerks-Ngam Abstract number: ThPeC7451

HIV vaccine awareness and recruitment marketing plan Authors: A. Wilcox. Abstract number: TuPeA4329

Tenth Brazilian Bulletin on HIV vaccines for AIDS NGOs Authors: J.A.B. Beloqui, R.O. Duda, G.C. Da Silva. Abstract number: E10563

Challenges and approaches to conducting HIV vaccine trials in the community Author: P. Pittisittithum. Abstract number: A10275

How to exert the potential of Community Advisory Board in the implementation of AIDS prevention program Author: K. Zhou, Y. Cui Abstract number: E12018

Recruitment:

Involving community members in HIV vaccine research programs Authors: M.B. Souza, M. Schechter, C.B. Yoshida, J. Pedrosa, G.R.S. Santos, A. Weinstein. Abstract number: WeOrE1341

Voluntary HIV counseling and testing as a source of participants for Phase I/II HIV vaccine trials in Soweto, South Africa Authors: E. Vardas, S. Mayaphi, T. Mashego, M. Mogale, M. Molapo-Matsoso, J. McIntyre, V. Khabule, G.E. Gray. Abstract number: ThPeC7436

Willingness to participate (WTP) in hypothetical HIV vaccine trials among communities at risk in Los Angeles, California, U.S.A. (Project VIBE) Authors: S.J. Lee, N. Duan, P.A. Newman, W.E. Cunningham, E. Rudy, D. S. Seiden, L. Kakinami. Abstract number: ThPeC7435

Willingness to participate in HIV vaccine trials among low and high risk populations in Pune, India Authors: S. Sahay, S.M. Mehendale, S.S. Sane, R.G. Brahme, A.S. Brown, K. Charron, C. Beyrer, R. C. Bollinger, R. S. Paranjape. Abstract number: ThPeC7437

HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics (Project VIBE) Authors: P.A. Newman, N. Duan, W. E. Cunningham, E. T. Rudy, S. J. Lee, D. Seiden. Abstract number: ThPeC7456

Predictors of willingness to participate in preventive AIDS vaccine trials: Implications for international trials Authors: A.S. Brown, V. Suriyanon, S. Sahay, R. Paranjape, R.C. Bollinger, S. Liu, X. Yu, R. Boss-Victoria, S. Strathdee, P. Chiliade, C. Harro, K.R. Charron, C. Beyrer. Abstract number: ThPeC7440

Recruitment of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil: Risk profile and willingness to participate in vaccine trials Authors: P.F. Barroso, S. Teles, S. B. Silva, M.F. Melo, E.P. Nunes, M.M.T. Almeida, M. Fernandes, R.F. Lago, L.H. Harrison, M. Schechter, NIAID, HVTN. Abstract number: ThPeC7453

Addressing barriers to women's enrollment in HIV vaccine trials Author: S. Kapoor. Abstract number: ThPeC7442

Willingness to participate in HIV vaccine trials in Congo (DRC) Authors: J.C. Olin, J. Kokolamami, D.B. Lapika, H. Bokole. Abstract number: C11130

Reasons for declining enrollment among eligible volunteers in a Phase II HIV vaccine trial in Kenya Authors: S. Wakasiaka, M. McBride, G.M. Omosa, K.K. Bwayo, K.A. Ndinya, W.G. Jaoko, A. Omu, H.A. Ogutu, W. Wambui. Abstract number: ThPeA7000

Mobilisation, recruitment and retention of volunteers in HIV vaccine trials; the Ugandan experience Authors: E. Mugisha, P. Kaleebu, L. Nielsen, F. Nakwagala, A. Nanvubya, J. de Bont, C. Konde, M. Warren, C. Schmidt Abstract number: ThPeA7006

Evaluation of recruitment and motivation for participation in two HIV vaccine trials, London, UK Authors: K.A. Gray, K. Legg, A. Sharp, N. Mackie, F. Olarinde, C. De Souza, B. Peters, J. Weber. Abstract number: ThPeC7430

Enhanced volunteer recruitment in HIV vaccine trials in Kenya Authors: S. Wakasiaka, J.J. Bwayo, J.A. Ndinya, W.G.Jaoko, A. Omu, G.M. Omosa, H.A. Ogutu, J. Nyange. Abstract number: ThPeA6999

Volunteers in preventive HIV vaccine trials. Motivations, determinants and biographical consequences in a longitudinal perspective (France, 1992-2001) Authors: O. Fillieule, A. Marijnen, P. Blanchard, C. Broqua. Abstract number: TuPeE5506

Capacity Building:

Developing laboratory infrastructure for HIV-1 vaccine clinical trials in resource constrained settings Authors: J.P. Stout, A. Tarragona, J. Birungi, A.O. Anzala, B. Farah, M. Thakar, P. Hayes, J.W. Gilmour. Abstract number: TuPeB4487

Quantifying global expenditures on AIDS vaccine R&D (research and design) Authors: A. Bing, D. Gold, G. Lamourelle, J. Rowley, S. Sadoff. Abstract number: TuPeE5325

Ghana's preparedness for HIV vaccine research Authors: C. Des Bouvrie, M Okai, M. Forgathy. Abstract number: ThPeC7427

Global cohort studies among IDUs and future HIV vaccine trials Authors: T. Woratanarat, C. Beyrer. Abstract number: WePeC5998

Implementing an information technology (IT) infrastructure for HIV vaccine clinical trials in resource-constrained settings Authors: R. Lima, G. Branch, A. Muluubya, D. Mark, E. Shutes, N. Ketter, P. Fast, L. Dorin. Abstract number: ThPeC7443

Spectrum of HIV-related illnesses at the National Social Security Hospital (Almenara Hospital) in Lima, Peru: Implications for HIV vaccine trials Authors: D. Corey, L. Gutierrez, R. Salazar, S. Tabet. Abstract number: C11494

Capacity building: training local health personnel to participate as research staff in the Phase III HIV vaccine trial in Chon Buri and Rayong provinces, eastern Thailand Authors: N. Premsri, T. Debysuvarn, T. Woratanarat, W. Wiriyakijja, S. Wattana, S. Chunsuttiwat, S. Rerks-Ngarm. Abstract number: ThPeC7449

Feasibility:

Feasibility perspectives of AIDS vaccine efficacy trials in India Author: J.L. Excler. Abstract number: ThOrC1431

The feasibility of epidemiology studies in African countries in preparation for large scale HIV vaccine efficacy trials Authors: S.B. Gupta, D.C. Freed, E. Vardas, B. Mbewe, J. Kublin, K. Long, V. Novitsky, P. Coplan, AT.C. Mast, W. Straus. Abstract number: ThPeC7452

School health programme accompanying HIV vaccine feasibility studies, Kilifi District, Kenya Authors: A. Davies, C. S. Molyneux, D. Kavoi, R. Waweru, E. M. van der Elst, N. Peshu, E.J. Sanders. Abstract number: TuPeD5131

Strategies to identify populations at risk for HIV infection for HIV vaccine efficacy trials in Kilifi District, Kenya Authors: E.J. Sanders, J.A.G. Whitworth, A. Davies, R. Waweru, E.M. van der Elst, M. Aluda, A. Scott, B. Lowe, K. Marsh, N. Peshu. Abstract number: ThPeC7447

Risk factors for HIV prevalence and incidence among mineworkers in South Africa: A potential setting for HIV vaccine trials Authors: S.M. Roux, K.L. Fielding, J.H. Day, V. Moloi, E. Magcuntsu, I Mantsoe, A.D. Grant, G.J. Churchyard. Abstract number: MoPeC3485

Clinical Issues:

Screening for low risk HIV vaccine trial participants in Kigali, Rwanda Authors: E. Shutes, S. Allen, J. Atkinson, K. Kayitenkore, A. Gopalakrishnan, A. Fraser-Bell, E. Karita. Abstract number: C11090

Retention of high-risk heterosexual men's and women's cohorts in a feasibility study of HIV vaccine trials in Sao Paulo, Brazil Authors: K. Wolffenbuttel, S. Caminada, R.M. Barbosa, A.O. Kalichman. Abstract number: ThPeC7460

The role of support groups in HIV vaccine cohort development in Kericho, Kenya Authors: K. Imbuki, G. Foglia, J. Mokaya, L. Langat, D. Birx, M. Robb. Abstract number: MoPeD3776

Care and treatment of HIV-infected injecting drug users (IDUs) during an HIV vaccine efficacy trial, Bangkok, Thailand Authors: M. Martin, W. Mansakul, J.W. Tappero, U. Sangkum, S. Vanichseni, P. Pitisuttithum, F. van Griensven, K. Orelind, K. Choopanya. Abstract number: MoPeB3350

Blood analyte screening data from potential HVTN Phase I preventive HIV vaccine trial participants in Botswana Authors: T. Villafana, P. Thumbi, B Ratshaa, K. Matshediso, K. Moyo, T. Maswabi, T. Peter, J. Makhema, M. Essex, I. Thior. Abstract number: ThPeC7450

Younger HIV vaccine trial participants report negative social impacts Authors: J. Fuchs, M. Durham, E. McLellan-Lemal, E. Vittinghoff, S. Buchbinder Abstract number: ThPeC7444

Retention of subjects in a multi-site international epidemiology study in preparation for large scale HIV vaccine efficacy trials Authors: S. B. Gupta, D. C. Freed, M. Schechter, E. Vardas, E.G. Kallas, P. Pitisuttithum, B. Mwebe, J. Kublin, E. Mpoudi-Ngole, V, Novitsky, A. Nikas, T.C. Nikas, T.C. Mast, P. Coplan, W. Straus. Abstract number: ThPeC7454

Ethics:

Ethical and legal issues in HIV vaccine research and development in Kenya - the case of the Kenya AIDS Vaccine Initiative (KAVI) and University of Oxford collaborative research in Nairobi Author: A.D.O. Rachier. Abstract number: MoPeE4208

An ethical framework for the care of volunteers in HIV vaccine trials in developing countries Author: B. Barugahare. Abstract number: C12300

Advocacy/Policy:

Developing coherent policy platforms for human rights advocacy around HIV vaccine development Authors: M. Morgan, M.A. Torres. Abstract number: ThPeE8198

Community-based organization advocating for HIV vaccines Authors: O. Valente, E. Tavora, W. Amaral. Abstract number: D10809

HIV treatment, vaccine and microbicide advocacy: developing a common international agenda for action Authors: R.E.F. Jurgens, J. Godwin, D. Patterson, S. Nixon, M.A. Torres, R. Elliott. Abstract number: TuPeE5380

Advocacy and policy design: the development of a Canadian HIV vaccines plan Authors: B. Bauer, I. Wellmeier, M. LeBlanc, K. Rosenthal, R. Jurgens. Abstract number: MoPeE4069